NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

IndexRUT P/E9.85 EPS (ttm)0.68 Insider Own43.39% Shs Outstand71.44M Perf Week1.98%
Market Cap477.94M Forward P/E3.94 EPS next Y1.70 Insider Trans0.00% Shs Float40.45M Perf Month7.90%
Enterprise Value316.93M PEG- EPS next Q- Inst Own49.25% Short Float7.57% Perf Quarter34.33%
Income48.53M P/S3.97 EPS this Y-18.29% Inst Trans-0.27% Short Ratio5.75 Perf Half Y24.80%
Sales120.33M P/B2.21 EPS next Y153.73% ROA19.80% Short Interest3.06M Perf YTD22.93%
Book/sh3.03 P/C2.95 EPS next 5Y- ROE25.47% 52W High11.62 -42.42% Perf Year-2.14%
Cash/sh2.27 P/FCF7.72 EPS past 3/5Y-3.24% - ROIC22.38% 52W Low4.48 49.25% Perf 3Y-22.73%
Dividend Est.0.60 (8.97%) EV/EBITDA5.56 Sales past 3/5Y1.24% 38.99% Gross Margin76.55% Volatility4.01% 3.96% Perf 5Y51.76%
Dividend TTM- EV/Sales2.63 EPS Y/Y TTM-39.03% Oper. Margin46.91% ATR (14)0.25 Perf 10Y534.45%
Dividend Ex-DateApr 29, 2025 Quick Ratio6.28 Sales Y/Y TTM-23.37% Profit Margin40.33% RSI (14)63.23 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio8.40 EPS Q/Q-103.97% SMA205.27% Beta0.94 Target Price11.00
Payout0.00% Debt/Eq0.01 Sales Q/Q-72.31% SMA5010.68% Rel Volume0.39 Prev Close6.68
Employees46 LT Debt/Eq0.00 EarningsMay 08 AMC SMA20014.68% Avg Volume531.98K Price6.69
IPOSep 09, 1997 Option/ShortYes / Yes EPS/Sales Surpr.- - Trades Volume209,179 Change0.15%
Jul-01-25 11:59AM
Jun-26-25 05:45PM
Jun-20-25 05:45PM
Jun-13-25 05:45PM
May-09-25 03:39AM
04:05PM Loading…
May-08-25 04:05PM
May-01-25 05:45PM
07:30AM
Apr-26-25 11:00AM
Apr-25-25 05:45PM
Apr-23-25 05:50PM
Apr-16-25 05:45PM
11:09AM
Apr-15-25 05:50PM
Apr-08-25 07:30AM
05:50PM Loading…
Apr-07-25 05:50PM
03:02AM
Mar-31-25 05:50PM
Mar-19-25 05:45PM
Mar-18-25 07:30AM
Mar-17-25 05:50PM
Mar-12-25 03:07AM
Mar-11-25 04:05PM
Mar-04-25 05:45PM
07:30AM
Feb-26-25 05:45PM
Feb-20-25 05:45PM
Feb-19-25 05:50PM
Feb-11-25 05:45PM
Feb-04-25 05:45PM
05:45PM Loading…
Jan-27-25 05:45PM
Jan-23-25 05:50PM
Jan-17-25 05:45PM
Jan-15-25 05:50PM
Jan-03-25 06:40AM
Jan-02-25 10:10AM
07:30AM
Dec-25-24 09:40AM
Dec-11-24 09:40AM
Dec-10-24 04:00PM
Dec-09-24 09:40AM
Dec-05-24 09:55AM
Nov-30-24 04:22PM
Nov-21-24 09:40AM
Nov-08-24 09:18AM
02:35AM
Nov-07-24 04:05PM
Oct-31-24 07:30AM
Oct-30-24 05:45PM
Oct-29-24 09:00PM
Oct-24-24 05:45PM
Oct-23-24 05:50PM
08:17AM
Oct-22-24 07:30AM
Oct-16-24 05:50PM
Oct-14-24 11:19AM
Oct-10-24 05:50PM
04:31PM
Oct-08-24 07:30AM
Oct-07-24 05:42PM
Oct-04-24 05:45PM
Oct-03-24 07:25PM
05:50PM
Sep-30-24 12:00AM
Sep-27-24 05:45PM
Sep-26-24 08:15AM
Sep-23-24 05:50PM
Sep-17-24 05:45PM
Sep-11-24 05:45PM
Aug-23-24 02:29PM
Aug-21-24 04:00PM
Aug-19-24 05:16PM
Aug-16-24 06:53AM
Aug-15-24 09:01AM
07:35AM
Aug-06-24 08:45AM
Aug-01-24 04:05PM
Jul-25-24 07:30AM
Jul-24-24 05:45PM
Jul-22-24 10:33AM
Jul-19-24 08:00AM
Jul-18-24 05:50PM
Jul-11-24 05:45PM
Jul-08-24 05:50PM
Jun-20-24 05:50PM
Jun-17-24 04:05PM
Jun-10-24 07:00AM
May-10-24 09:40AM
May-08-24 09:05AM
06:45AM
May-07-24 04:05PM
May-03-24 12:00PM
May-02-24 05:45PM
May-01-24 05:00PM
Apr-25-24 05:45PM
Apr-19-24 05:45PM
Apr-15-24 05:50PM
Apr-01-24 04:05PM
Mar-25-24 07:30AM
Mar-21-24 12:00PM
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of solutions for medical needs and biothreats. The firm develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other viruses. It offers an orally administered antiviral drug that targets orthopoxviruses under the TPOXX brand. The company was founded by Steven Oliveira on December 28, 1995 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Luckshire Daniel JExecutive VP & CFOJul 01 '25Option Exercise0.0024,1930287,410Jul 02 09:03 PM
Hruby Dennis EEVP & Chief Scientific OfficerJul 01 '25Option Exercise0.0032,2580201,514Jul 02 08:58 PM
Miller Larry R.General CounselApr 18 '25Option Exercise0.006,920041,976Apr 21 05:00 PM
Miller Larry R.General CounselMar 25 '25Option Exercise0.006,920037,820Mar 26 05:01 PM
Nguyen DiemChief Executive OfficerJan 27 '25Option Exercise0.0055,902091,297Jan 29 05:07 PM
Nguyen DiemChief Executive OfficerOct 25 '24Option Exercise0.0059,288059,288Oct 29 05:03 PM